FDA.reportPublic FDA data

DSUVIA 30 MCG Sublingual Tablet

RxCUI
2103199
RxNorm name
DSUVIA 30 MCG Sublingual Tablet
Display name
DSUVIA 30 MCG Sublingual Tablet
Full name
DSUVIA 30 MCG Sublingual Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8b580f3d-e3b5-4086-b093-87a980631147DSUVIA 30 MCG Sublingual Tablet [PSN] · sufentanil 0.03 MG Sublingual Tablet [Dsuvia] [SBD] · Dsuvia 0.03 MG Sublingual Tablet [SY] · Dsuvia 30 MCG Sublingual Tablet [SY]48These highlights do not include all the information needed to use DSUVIA ® safely and effectively. See full prescribing information for DSUVIA ® . DSUVIA ® (sufentanil) sublingual tablet, CII Initial U.S. Approval: 198420251230